Profound Financial Statements From 2010 to 2024

PROF Stock  USD 7.52  0.03  0.40%   
Profound Medical financial statements provide useful quarterly and yearly information to potential Profound Medical Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Profound Medical financial statements helps investors assess Profound Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Profound Medical's valuation are summarized below:
Gross Profit
M
Market Capitalization
187.2 M
Enterprise Value Revenue
18.5063
Revenue
M
Earnings Share
(1.34)
There are over one hundred nineteen available trending fundamental ratios for Profound Medical Corp, which can be analyzed over time and compared to other ratios. Active traders should verify all of Profound Medical Corp recent fundamental drivers against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. The Profound Medical's current Market Cap is estimated to increase to about 252.8 M. The Profound Medical's current Enterprise Value is estimated to increase to about 206.9 M

Profound Medical Total Revenue

4.67 Million

Check Profound Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Profound Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 731 K or Selling General Administrative of 6.9 M, as well as many indicators such as Price To Sales Ratio of 25.53, Dividend Yield of 0.0 or PTB Ratio of 3.51. Profound financial statements analysis is a perfect complement when working with Profound Medical Valuation or Volatility modules.
  
Check out the analysis of Profound Medical Correlation against competitors.

Profound Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets46.2 M43.7 M31.5 M
Slightly volatile
Short and Long Term Debt Total6.9 M7.9 M5.4 M
Slightly volatile
Total Current Liabilities5.1 M6.4 M3.5 M
Slightly volatile
Total Stockholder Equity36.2 M31.2 M24.7 M
Slightly volatile
Property Plant And Equipment Net1.4 M1.5 MM
Slightly volatile
Accounts Payable2.6 M3.3 M1.8 M
Slightly volatile
Cash32.4 M26.2 M22.2 M
Slightly volatile
Non Current Assets Total1.9 MM3.1 M
Slightly volatile
Cash And Short Term Investments33.2 M26.1 M22.7 M
Slightly volatile
Net Receivables3.8 M7.3 M2.9 M
Slightly volatile
Common Stock Total Equity255.4 M243.3 M106.7 M
Slightly volatile
Common Stock Shares Outstanding12.5 M21.2 M8.5 M
Slightly volatile
Liabilities And Stockholders Equity46.2 M43.7 M31.5 M
Slightly volatile
Non Current Liabilities Total5.2 M6.4 M4.2 M
Slightly volatile
Other Stockholder Equity32.6 M19.7 M22.1 M
Slightly volatile
Total Liabilities10.1 M12.7 M6.8 M
Slightly volatile
Property Plant And Equipment GrossM4.8 M1.6 M
Slightly volatile
Total Current Assets41.4 M41.9 M28.3 M
Slightly volatile
Short Term Debt1.7 M2.4 M1.4 M
Pretty Stable
Intangible Assets463.1 K487.5 K985.9 K
Slightly volatile
Common Stock135.6 M217.4 M91.6 M
Slightly volatile
Other Liabilities1.1 M878.6 K721.9 K
Slightly volatile
Net Tangible Assets38 M59 M27.3 M
Slightly volatile
Long Term Debt6.1 MM5.7 M
Pretty Stable
Long Term Debt Total6.4 M10.2 M6.7 M
Slightly volatile
Capital Surpluse23.6 M22.5 M10.8 M
Slightly volatile
Short and Long Term Debt2.6 M2.1 M1.4 M
Slightly volatile
Property Plant Equipment1.7 MM1.1 M
Slightly volatile
Net Invested Capital53.8 M38.3 M33.6 M
Slightly volatile
Net Working Capital47.3 M35.5 M25.8 M
Slightly volatile
Capital Stock191.2 M217.4 M129.6 M
Slightly volatile

Profound Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.1 M1.1 M785.5 K
Slightly volatile
Interest Expense731 K932.8 K696 K
Very volatile
Selling General Administrative6.9 M9.2 M5.1 M
Slightly volatile
Other Operating Expenses23.5 M35.8 M17 M
Slightly volatile
Research Development10.2 M14.4 M7.5 M
Slightly volatile
Total Operating Expenses21.4 M33.6 M15.5 M
Slightly volatile
Interest Income1.7 M1.6 MM
Pretty Stable
Selling And Marketing Expenses5.5 M9.5 M3.4 M
Slightly volatile
Reconciled Depreciation1.5 M1.1 M1.1 M
Slightly volatile

Profound Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2.5 M3.4 M1.7 M
Slightly volatile
Begin Period Cash Flow29.6 M46.5 M20.1 M
Slightly volatile
Depreciation1.1 M1.2 M759.8 K
Slightly volatile
Other Non Cash Items7.2 M6.8 M3.7 M
Pretty Stable
Total Cash From Financing Activities1.4 M1.5 M12.5 M
Pretty Stable
End Period Cash Flow32.6 M26.1 M22.8 M
Slightly volatile
Sale Purchase Of Stock15.6 M10.4 M18.5 M
Slightly volatile
Change To Netincome4.6 M7.9 M4.6 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio25.5324.623423.9419
Slightly volatile
PTB Ratio3.515.68523.5831
Slightly volatile
Days Sales Outstanding324370315
Pretty Stable
Book Value Per Share1.41.4723.8993
Slightly volatile
Average Payables2.5 M2.4 M1.4 M
Slightly volatile
Stock Based Compensation To Revenue0.410.47460.3923
Slightly volatile
Capex To Depreciation0.340.360.8777
Pretty Stable
PB Ratio3.515.68523.5831
Slightly volatile
EV To Sales21.1422.085320.5216
Slightly volatile
Payables Turnover0.680.85830.5564
Slightly volatile
Sales General And Administrative To Revenue1.631.27351.3657
Slightly volatile
Research And Ddevelopement To Revenue2.511.99712.1471
Pretty Stable
Capex To Revenue0.07540.09920.0829
Slightly volatile
Cash Per Share1.181.23754.1146
Slightly volatile
Days Payables Outstanding8044251.5 K
Slightly volatile
Income Quality0.620.78050.647
Slightly volatile
Intangibles To Total Assets0.01060.01120.0593
Very volatile
Current Ratio8.396.581211.3704
Pretty Stable
Tangible Book Value Per Share1.381.44883.6654
Slightly volatile
Receivables Turnover1.340.98781.3779
Pretty Stable
Graham Number6.356.683431.4854
Slightly volatile
Shareholders Equity Per Share1.41.4723.8993
Slightly volatile
Debt To Equity0.220.22780.9361
Slightly volatile
Capex Per Share0.03170.03330.1265
Slightly volatile
Graham Net Net1.011.05953.5057
Slightly volatile
Average ReceivablesM3.1 M3.8 M
Slightly volatile
Revenue Per Share0.420.33990.4995
Slightly volatile
Interest Debt Per Share0.350.37175.1702
Slightly volatile
Debt To Assets0.150.16180.7903
Slightly volatile
Operating Cycle7561.3 K728
Slightly volatile
Price Book Value Ratio3.515.68523.5831
Slightly volatile
Days Of Payables Outstanding8044251.5 K
Slightly volatile
Ebt Per Ebit1.181.00281.2794
Slightly volatile
Company Equity Multiplier1.631.40831.382
Slightly volatile
Long Term Debt To Capitalization0.130.13820.3342
Slightly volatile
Total Debt To Capitalization0.180.18560.4006
Slightly volatile
Debt Equity Ratio0.220.22780.9361
Slightly volatile
Quick Ratio7.835.483310.8656
Slightly volatile
Net Income Per E B T0.80.99550.9975
Slightly volatile
Cash Ratio6.594.11779.7513
Slightly volatile
Days Of Sales Outstanding324370315
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.131.181.0428
Slightly volatile
Price To Book Ratio3.515.68523.5831
Slightly volatile
Fixed Asset Turnover2.554.72072.9849
Slightly volatile
Debt Ratio0.150.16180.7903
Slightly volatile
Price Sales Ratio25.5324.623423.9419
Slightly volatile
Asset Turnover0.120.16390.1428
Slightly volatile
Gross Profit Margin0.370.60870.4186
Slightly volatile
Price Fair Value3.515.68523.5831
Slightly volatile

Profound Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap252.8 M177.3 M191.6 M
Slightly volatile
Enterprise Value206.9 M159 M172.4 M
Slightly volatile

Profound Fundamental Market Drivers

Cash And Short Term Investments26.1 M

Profound Upcoming Events

5th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Profound Medical Financial Statements

Profound Medical stakeholders use historical fundamental indicators, such as Profound Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Profound Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Profound Medical's assets and liabilities are reflected in the revenues and expenses on Profound Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Profound Medical Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue721 K384.1 K
Total Revenue7.3 M4.7 M
Cost Of Revenue2.8 M2.7 M
Stock Based Compensation To Revenue 0.47  0.41 
Sales General And Administrative To Revenue 1.27  1.63 
Research And Ddevelopement To Revenue 2.00  2.51 
Capex To Revenue 0.10  0.08 
Revenue Per Share 0.34  0.42 
Ebit Per Revenue(3.97)(4.17)

Currently Active Assets on Macroaxis

When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:
Check out the analysis of Profound Medical Correlation against competitors.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.34)
Revenue Per Share
0.38
Quarterly Revenue Growth
0.639
Return On Assets
(0.45)
Return On Equity
(0.90)
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.